Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multikinase refers to a class of enzymes or inhibitors that target multiple kinases simultaneously. These kinases are enzymes that catalyze the transfer of phosphate groups to specific substrates, playing crucial roles in signaling pathways that regulate cell growth, differentiation, survival, and other vital processes. Multikinase inhibitors are small molecules designed to inhibit several membrane-bound and intracellular kinases at once. By blocking multiple signaling pathways simultaneously—such as those involving VEGFRs, PDGFRs, RET kinase, BRAF kinase—multikinase inhibitors can disrupt cancer cell proliferation and survival more effectively than single-target agents.
Inhibition/blockade of several protein/receptor tyrosine kinases
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multikinase.